Guerbet
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Guerbet (Euronext: GBT) is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.[1]
In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters, formerly located in Villepinte, is currently located in Chicago, and its shares are included in the NASDAQ stock index.
In July 2015, Guerbet announced the takeover of a portion of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015.[citation needed]
References
- ^ "Corporate history". Guerbet Group website. Retrieved 8 January 2019.
External links
- Articles needing additional references from January 2019
- All articles needing additional references
- Articles with topics of unclear notability from January 2019
- All articles with topics of unclear notability
- Company articles with topics of unclear notability
- Articles needing translation from French Wikipedia
- Articles with multiple maintenance issues
- All articles with unsourced statements
- Articles with unsourced statements from July 2022
- Official website different in Wikidata and Wikipedia
- Articles with ISNI identifiers
- Articles with VIAF identifiers
- Articles with BNF identifiers
- Articles with BNFdata identifiers
- Articles with SUDOC identifiers
- Healthcare companies of France
- Health care companies established in 1926
- French companies established in 1926
- Companies listed on Euronext Paris
- All stub articles
- French company stubs